What is UAMY's health score?

UNITED STATES ANTIMONY CORP (UAMY) has a TradeApes health score of 30 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is UAMY's estimated fair value?

Based on our 5-year discounted cash flow model, UNITED STATES ANTIMONY CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is UAMY undervalued or overvalued?

Our model currently rates UAMY as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for UAMY... Refresh in a moment for the full analysis.

UNITED STATES ANTIMONY CORP (UAMY)

Materials Inconclusive inconclusive weak

$8.98

Updated: 2026-05-30

TradeApes Score

Financial Strength

30 Weak

Operating Trend

40 Weak

Relative Value

0 Stressed

Capital Allocation

65 Healthy

Risk

30 Weak

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.